ACRS

ACLARIS THERAPEUTICS INC

Healthcare | Small Cap

-$0.16

EPS Forecast

$1.48

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.16

Revenue Forecast:

$1.48

EPS Surprise Forecast:

$0.004

Revenue Surprise Forecast:

$0

Post-release price volatility - High

Post-release Overnight Move:

±8.8%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

58%

Probability of beating revenue consensus:

59%

Probability of beating both EPS & revs consensus:

40%

Probability of missing both EPS & revs consensus:

23%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

0.86

Earnings volatility

EPS standard deviation:

$0.05

Revenue standard deviation:

$2

As % of share price:

1.36% HIGH

As % of market cap:

0.45% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.10

Revenue 95th %ile:

$4

EPS 75th %ile:

-$0.14

Revenue 75th %ile:

$2

EPS 25th %ile:

-$0.18

Revenue 25th %ile:

$1

EPS 5th %ile:

-$0.22

Revenue 5th %ile:

-$0

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

36% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$32

Bid-ask per Share:

$0.01